Long-Term Concerns at Intuitive? Here's What I'm Doing and Why.

Shareholders of Intuitive Surgical (NASDAQ: ISRG  ) , maker of the da Vinci Robotic Surgical System, have endured a perplexing couple of months.

First, several members of the medical community began questioning whether the company's machine was necessarily helping hysterectomy patients. Then yesterday, the company came out with earnings that well exceeded expectations, only to see the stock dive further today.

The results
It's never good to live and die by expectations; but Intuitive clearly brought in and made more money last quarter than many were expecting.

 

Revenue

Earnings

Expected

$583 million

 $3.99

Actual

$611 million

 $4.56

Surprise %

5%

14%

Year-Over-Year Growth

23%

30%

Source: SEC filings. 

The business itself is divided into three divisions. The first, Instruments, is responsible for selling disposable parts that a hospital must buy in order to perform certain surgeries. The second, Systems, is the one actually selling the da Vinci robots to hospitals. The third, much smaller division is Service, which visits hospital sites to make sure the machines continue to function properly.

Here's how they fared during the first quarter.

Source: SEC filings. 

Though the company experienced a 30% growth in earnings, after today's 4% decline, today's P/E of 29 seems about fair. But Intuitive has always tended to trade above its growth rate; and the question for investors is: "Why did that trend stop?"

Causes for concern
There are two primary reasons Intuitive's stock isn't getting as much love as it once had. For starters, guidance was lower than investors were hoping for in the second quarter. It's important to remember, however, that guidance is just that -- an educated guess. And while it serves as a data point, it's a very short-term one at that.

The larger concern is likely the press that's started to question whether the da Vinci is needed for minimally invasive hysterectomies. Some may look to what's happened in prostatectomies in the past as a blue print.

As CEO Dr. Gary Guthart explained in 2012, there was a change in prostate "screening protocols and a change in treatment recommendations for low-risk cancer patients away from definitive treatment." These changes contributed to a 15% decline in prostate procedures in the United States.

If protocols were changed for hysterectomies, it isn't out of the realm of possibility to see a similar decline in hysterectomies.

What I'll be doing
I'm not a doctor, nor would I pretend to know anything about performing hysterectomies, prostatectomies, or any other procedures that Intuitive has made its name in. At the same time, I'm a student of disruptive technologies, and see da Vinci as a prime example of a disruptive technology.

There may be some tough times ahead for the company's stock, but as far as long-term concerns for the company and its procedures go, there was a great point made at the end of the conference call investors should remember. Guthart relayed what a surgeon had told him: "Open surgery hasn't gotten any better for patients, and laparoscopy hasn't gotten any easier for surgeons."

In other words, traditional surgery is probably as good as it'll ever get right now. It might be better than da Vinci right now, or it might not. But the point is, there's still tons of room for improvement. I'm not adding shares right now, but I'm also not selling for this very point.

If you'd like a deeper dive into Intuitive, as well as real-time updates on the company throughout the year, I suggest you check out our special premium report on the company.  Be sure to claim your copy by clicking here now.


Read/Post Comments (1) | Recommend This Article (6)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On April 19, 2013, at 2:08 PM, BabsD wrote:

    Herb Greenberg has an investigative report on CNBC trashing Intuitive Surgical. I have admired the company, and made money with it -- so it's hard to know how to react to what he's saying. The obvious way would be "sell."

Add your comment.

DocumentId: 2373950, ~/Articles/ArticleHandler.aspx, 4/23/2014 9:37:39 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement